Massachusetts House Recognizes National Multiple Sclerosis Society for MS Research and Advocacy

On May 12, 2024, Massachusetts State Representatives Mindy Domb and Ted Philips stood at the State House in Boston to present a landmark resolution to the National Multiple Sclerosis (MS) Society—an annual tradition known as State Action Day. The resolution, co-sponsored by 76 colleagues in the Massachusetts House of Representatives, formally recognized the society’s pivotal role in advancing MS research, treatment, and patient support over nearly eight decades. This year’s action marks a significant moment in the state’s legislative history, as it represents the first time the Massachusetts House has formally acknowledged the National MS Society’s contributions on this scale.

The resolution comes as the National MS Society prepares to celebrate its 78th anniversary in 2024, having invested over $1 billion in MS research since its founding in 1946. This funding has directly supported breakthroughs in disease-modifying therapies, early diagnosis protocols, and the training of researchers at institutions like Harvard Medical School, Massachusetts General Hospital, and the Broad Institute of MIT and Harvard. The society’s work extends beyond research, offering critical resources for the estimated 2.8 million people worldwide living with MS, including personalized care programs, employment support, and advocacy for policy changes that improve access to treatment.

For Rep. Domb, the resolution is a testament to the society’s dual mission: advancing scientific progress while ensuring that individuals with MS and their families receive the support they need to thrive. “Early diagnosis of MS can change everything—it can validate a patient’s experience, lead to timely treatment that delays progression, and ultimately improve quality of life,” Domb said in a statement. “The National MS Society doesn’t just fund research; they build awareness and equip communities with the tools to respond to this disease with compassion and action.”

Why This Resolution Matters: The National MS Society’s Impact on Global Health

The National MS Society’s influence extends far beyond Massachusetts, shaping global MS research and patient care through strategic partnerships and funding. According to the society’s 2023 annual report, its investments have contributed to:

• 15 approved disease-modifying therapies since 2000, transforming MS from a relentlessly progressive condition to one that can be managed with treatment [source].
• Support for over 1,200 researchers at 130 institutions worldwide, including the Harvard Medical School and Massachusetts General Hospital, where groundbreaking work on MS genetics and immunotherapy is underway.
• A network of 50 chapters and 1,000 volunteers in the U.S., providing direct services to patients, from peer support groups to adaptive sports programs [source].

Rep. Philips echoed the importance of legislative support, noting that the resolution reflects a growing bipartisan commitment to MS advocacy. “This isn’t just about funding research—it’s about recognizing the human cost of MS and the resilience of those who live with it every day,” Philips said. “Our goal is to accelerate progress toward a cure while ensuring no one faces this diagnosis alone.”

State Action Day: How Massachusetts Joins a National Effort

May 12 has been designated as National MS Society State Action Day since 1999, a day when state legislators across the U.S. Introduce resolutions, proclamations, or bills to honor the society’s work. This year, Massachusetts’ resolution stands out for its breadth, with Rep. Domb and Philips leading an effort that included co-sponsorship from 76 representatives—a record for the state. Similar actions have taken place in other states, including:

• California, where Gov. Gavin Newsom issued a proclamation in 2023 recognizing the society’s work [source].
• New York, where State Sen. Kevin Thomas introduced a resolution in 2022 to expand MS research funding [source].
• Texas, where the state legislature passed a resolution in 2021 designating May as MS Awareness Month [source].

The Massachusetts resolution also highlights the society’s role in public health advocacy, including efforts to improve insurance coverage for MS treatments and remove barriers to care. For example, the society has been instrumental in pushing for policies that:

• Expand access to disease-modifying therapies (DMTs) through Medicaid and Medicare [source].
• Fund MS research at the National Institutes of Health (NIH), which has seen a 40% increase in MS-related funding since 2015 [source].
• Support telemedicine programs for rural patients, who often face delays in diagnosis and treatment [source].

Beyond the Resolution: What MS Means for Patients and Families

While the Massachusetts resolution is a legislative milestone, its true impact lies in the lives of those affected by MS. According to the Centers for Disease Control and Prevention (CDC), MS affects approximately 1 million people in the U.S. Alone, with symptoms ranging from fatigue and mobility challenges to cognitive difficulties. Early diagnosis and treatment can significantly alter the course of the disease, yet disparities in access remain a critical issue.

“When I was diagnosed in 2018, I had no idea how much the National MS Society would become part of my support system,” said Sarah Chen, a 34-year-old resident of Boston who was diagnosed with relapsing-remitting MS. “Their local chapter connected me with a support group, helped me navigate insurance appeals for my DMT, and even matched me with a physical therapist who specialized in MS. Without them, I wouldn’t have been able to return to teaching.”

Chen’s experience reflects the society’s holistic approach to care, which combines medical research with community-based support. Programs like the MS Navigator Program provide one-on-one assistance to patients, helping them access resources like assistive technology, employment accommodations, and mental health services. The society also operates 24/7 helplines staffed by trained counselors and MS specialists.

What Happens Next? Key Developments in MS Research and Policy

The Massachusetts resolution is not just a symbolic gesture—it signals a renewed focus on MS at both the state and federal levels. Here’s what to watch in the coming months:

• Federal Funding for MS Research: The U.S. Congress is expected to debate the FY 2025 NIH budget, with advocates pushing for increased funding for MS research. The National MS Society has set a goal of $500 million annually for MS research by 2030.
• State-Level Policy Changes: Massachusetts lawmakers may introduce bills in the next legislative session to expand Medicaid coverage for high-cost DMTs, following similar efforts in states like New York and California.
• Clinical Trials and Breakthroughs: The society is funding 12 new clinical trials in 2024, including research into stem cell therapies and neuroprotective agents that could halt MS progression entirely.